Eli Lilly Corp. buy Barclays PLC
Start price
23.01.24
/
50%
€580.50
Target price
23.01.25
€625.12
Performance (%)
26.43%
Price
30.04.24
€732.70
Summary
This prediction is currently active. The prediction currently has a performance of 26.43%. Dividends of €1.21 are taken into consideration when calculating the performance. This prediction currently runs until 23.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | 5.213% | 5.213% |
iShares Core DAX® | -1.370% | -3.231% |
iShares Nasdaq 100 | 0.172% | -3.339% |
iShares Nikkei 225® | -0.801% | -7.859% |
iShares S&P 500 | -0.369% | -2.979% |
Comments by Barclays_PLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Barclays PLC from $630.00 to $680.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat